Haynes Boone Represents Strides Pharma Science in $24 Million Acquisition
A Haynes and Boone, LLP deal team led by Simin Sun and Jeff Wolfson is representing Strides Pharma Science Limited in a $24 million acquisition announced Aug. 6, 2021.
Strides announced that its wholly owned subsidiaries have entered into definitive agreements with subsidiaries of Endo International to acquire its manufacturing facility in New York and various Abbreviated New Drug Applications (ANDAs).
The acquisition is expected to close this year and, Strides said, will further bolster its U.S. presence through acquisition of a multi-dosage facility in the U.S. and a basket of ANDAs across multiple therapeutic segments. The cumulative addressable market for the acquired portfolio is $4.7 billion.
A partner in Haynes Boone’s Houston office, Sun assists clients in connection with complex mergers and acquisitions (both on the buyer and seller side), especially those that contain a technology or international component. Wolfson, a Washington, D.C., partner and chair of the firm’s Patent Prosecution Practice Group, helps clients manage their intellectual property portfolios and product launch risks, including pharmaceutical partnering arrangements and conducting IP diligence evaluations in connection with M&A matters.
The lawyers were joined on the deal team by: Partner Greg Kramer and Associates Reem Abdelrazik and Maseo Brown. Additional counsel was provided by an interdisciplinary Haynes Boone team, including: Raquel Alvarenga; Scott Thompson; Lucy Hong; Mordechai Sutton; Jack Turano; Suzie Trigg; Tony Subketkaew; Jeff Civins; Randall Colson; Ed Lebow; Matt Deffebach and Jennifer Kreick.
Haynes Boone M&A lawyers have comprehensive experience handling middle market deals (including in the pharmaceutical and insurance industries), having helped clients close more than 500 transactions in the last five years, with an aggregate value exceeding $40 billion. The group routinely represents private equity firms, closely held corporations, founders, large financial institutions, and Fortune 500 public companies. Haynes Boone’s M&A Practice Group was ranked among the top firms in Texas (Band 4) by Chambers USA (Chambers and Partners) in 2021.
Haynes and Boone, LLP is an international corporate law firm with offices in Texas, New York, California, Charlotte, Chicago, Denver, Washington, D.C., London, Mexico City and Shanghai, providing a full spectrum of legal services in energy, technology, financial services and private equity. With 600 lawyers, Haynes Boone is ranked among the largest U.S.-based firms by The National Law Journal, The American Lawyer and The Lawyer. It was recognized for excellence in the BTI Consulting Group’s 2021 “A-Team” report, which identifies the law firms that in-house counsel commend for providing superior client service. See the firm’s new brand and website at haynesboone.com.
Strides, listed on the BSE (532531) and National Stock Exchange of India Limited (STAR), is a global pharmaceutical company headquartered in Bengaluru, India. The Company mainly operates in the regulated markets and has an “in Africa for Africa” strategy along with an institutional business to service donor-funded markets. The Company’s global manufacturing sites are located in India (Chennai, Puducherry and two locations in Bengaluru), Singapore, Italy (Milan), Kenya (Nairobi) and the United States (Florida). The Company focusses on “difficult to manufacture” products that are sold in over 100 countries. Additional information is available at the Company’s website at www.strides.com.